(AGENPARL) – lun 02 gennaio 2023 Hansa Biopharma announces positive reimbursement decision for Idefirix® (imlifidase) in the Czech Republic -…
Browsing: idefirix
(AGENPARL) – ven 09 dicembre 2022 Hansa Biopharma announces positive reimbursement decision in Italy for Idefirix® (imlifidase) as desensitization treatment…